Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-256

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 51655-256). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 256 52 Rev A 03 23)

Label (51655 256 52   Rev A 03 23)
This is a description of Rosuvastatin Calcium tablets, USP in 10mg strength. The packaging contains 30 tablets and is only available with a prescription (Rx Only). The tablets should be stored at 20-25°C (68-77°F) and kept in the original container to protect from moisture. The lot number is 0000000000, and it was repackaged by Northwind Pharmaceuticals from the lot number 68462-262-xx of Glenmark Pharmaceuticals Inc., USA. This medicine is used to lower cholesterol levels in the blood.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
This appears to be a description of some sort of statistical analysis. The first line provides a value of 8 with a confidence interval of 0.46-0.69. The second line shows a value of 71 with a p-value of less than 0.001. The remainder of the text appears to be a table showing cumulative incidence and the number of cases at risk for two different groups (R3SV and Placebo). Without more context, it is unclear what this data represents or how it was collected.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
The given text provides statistical data for a drug called Rosuva in comparison to a Placebo drug which includes information on the number of events and endpoints observed for each drug. The data suggests that Rosuva 20mg is more effective than Placebo 20mg in preventing primary endpoint (MCE). Rosuva showed less nonfatal stroke and nonfatal MI occurrences in comparison to Placebo. Additionally, Rosuva resulted in fewer cardiovascular deaths and arterial revascularizations.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin are different types of cholesterol-lowering medications that are available in different doses (10, 20, 40, and 80 mg). However, the provided information is incomplete and contains unreadable characters.*
FDA Label Image
Logo (Logo)
This is not enough text to generate a useful description. It seems to be a company name or a single letter.*
FDA Label Image

Logo1 (Logo1)

Logo1 (Logo1)
This description is not useful as it consists of only two words "G" and "glenmark".*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.